WILLIAMS AND JENSEN, PLLC for BIOGEN IDEC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Issues related to newborn screening programs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | COS, Rep Van Hilleary and Majority Whip |
| CHERYL LYNN JAEGER | Shared employee, Ofc of the Speaker & Ofc of VA 7; Sr. Policy Adv, Maj Leader, Rep Cantor; Sr Policy Adv, Rep Whip, Rep Cantor; Sr Policy Adv, Majority Whip Rep. Blunt; Prof Staff House Committee on E&C; Sr. LA to Rep Cox |
Medicare/Medicaid MMM
CMMI Medicare Part B demonstration; General education about policies impacting pharmaceutical development, approval, and reimbursement, including Medicare payment policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHERYL LYNN JAEGER | — |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Medical/Disease Research/Clinical Labs MED
21st Century Cures Initiative, H.R. 6 (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee); medical research at NIH.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHERYL LYNN JAEGER | — |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Health Issues HCR
General education about policies impacting pharmaceutical development, approval, and reimbursement; 340 B program; 21st Century Cures Initiative, H.R. 6 (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee), including efforts to advance precision medicine. S. 1878, Advancing Hope Act of 2016.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHERYL LYNN JAEGER | — |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.